ESTIMATED
05/15/2024
05/15/2024
Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2024 | 0 | -$0.12 | -$0.12 | -$0.12 |
Q2 2024 | 1 | -$0.11 | -$0.11 | -$0.11 |
Q3 2024 | 0 | $1.54 | $1.54 | $1.54 |
Anebulo Pharmaceuticals, Inc. last posted its earnings results on Wednesday, May 15th, 2024. The company reported $-0.06 earnings per share for the quarter, topping analysts' consensus estimates of $-0.11 by $0.05. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Anebulo Pharmaceuticals, Inc. has generated $0 earnings per share over the last year ($-0.47 diluted earnings per share) and currently has a price-to-earnings ratio of -7.57. Anebulo Pharmaceuticals, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, September 18th, 2024 based on prior year's report dates.
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue | 05/15/2024 | Q3 2024 | -$0.11 | -$0.06 | 0.05 | $0 | $0 | 02/13/2024 | Q2 2024 | -$0.11 | -$0.11 | 0 | $0 | $0 | 11/14/2023 | Q1 2024 | -$0.11 | -$0.10 | 0.01 | $0 | 09/22/2023 | Q4 2023 | -$0.10 | $0 | 05/11/2023 | Q3 2023 | -$0.16 | -$0.11 | 0.05 | $0 | 02/10/2023 | Q2 2023 | -$0.11 | -$0.15 | -0.04 | $0 | 11/10/2022 | Q1 2023 | -$0.10 | -$0.11 | -0.01 | $0 | 06/30/2022 | Q4 2022 | -$0.10 | $0 | 05/11/2022 | Q3 2022 | -$0.05 | -$0.08 | -0.03 | $0 | 02/11/2022 | Q2 2022 | -$0.06 | -$0.05 | 0.01 | $0 | 11/12/2021 | Q1 2022 | -$0.07 | $0 | 09/22/2021 | Q4 2021 | -$0.00 | -$1.59 | -1.59 | $0 | 06/21/2021 | Q3 2021 | -$0.04 | -$0.02 | 0.02 | $0 | 12/31/2020 | Q2 2021 | -$0.01 | $0 | 09/30/2020 | Q1 2021 | -$0.01 | $0 |
---|
A. Anebulo Pharmaceuticals, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, September 18th, 2024 based off last year's report dates.
A. In the previous quarter, Anebulo Pharmaceuticals, Inc. (NASDAQ:ANEB) reported $-0.06 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.11 by $0.05.
A. The conference call for Anebulo Pharmaceuticals, Inc.'s latest earnings report can be listened to online.
A. The conference call transcript for Anebulo Pharmaceuticals, Inc.'s latest earnings report can be read online.
A. Anebulo Pharmaceuticals, Inc. (NASDAQ:ANEB) has a recorded net income of $0. Anebulo Pharmaceuticals, Inc. has generated $-0.47 earnings per share over the last four quarters.
A. Anebulo Pharmaceuticals, Inc. (NASDAQ:ANEB) has a price-to-earnings ratio of -7.57 and price/earnings-to-growth ratio is 0.12.